Our previous studies found that recombinant IL-37 exerts potent protective effects on CAVD and that recombinant IL-37 alleviates MyD88-mediated inflammatory mediator production after stimulating TLR2/4 in HAVICs [33]. The gene discussed is IL37; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.